Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal-Reference-Cited by-同舟云学术

Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal

Author:

Santharam Sandhya¹²³,Fountas Athanasios¹²³,Tampourlou Metaxia¹²³,Arlt Wiebke¹²³,Ayuk John²³,Gittoes Neil¹²³,Toogood Andrew²³,Karavitaki Niki¹²³^ORCID

Affiliation:

1. Institute of Metabolism and Systems Research (IMSR); College of Medical and Dental Sciences; University of Birmingham; Birmingham UK

2. Centre for Endocrinology, Diabetes and Metabolism; Birmingham Health Partners; Birmingham UK

3. Department of Endocrinology; Queen Elizabeth Hospital; University Hospitals Birmingham NHS Foundation Trust; Birmingham UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

Reference21 articles.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolated hypoprolactinemia: The rarest of the rare?;Reviews in Endocrine and Metabolic Disorders;2024-09-13

4. Hyperprolactinemia in women: treatment;Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics;2024